Opus Genetics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Opus Genetics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Opus Genetics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.01M, a 225% decline year-over-year.
  • Opus Genetics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$29.5M, a 201% decline year-over-year.
  • Opus Genetics, Inc. annual Operating Income (Loss) for 2023 was -$10.6M, a 158% decline from 2022.
  • Opus Genetics, Inc. annual Operating Income (Loss) for 2022 was $18.2M.
  • Opus Genetics, Inc. annual Operating Income (Loss) for 2021 was -$22.7M, a 13.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$29.5M -$8.01M -$14.4M -225% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$15.1M -$8.33M -$2.94M -54.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$12.1M -$7.71M -$1.58M -25.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$10.6M -$5.43M -$39.6M -116% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $29.1M $6.39M +$10.9M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $18.2M -$5.39M -$451K -9.13% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $18.6M -$6.13M +$377K +5.79% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $18.2M $34.2M +$40.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 -$22.1M -$4.54M -$306K -7.23% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$21.8M -$4.94M +$2.2M +30.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$24M -$6.51M -$1.32M -25.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$22.7M -$6.15M +$7.87M +56.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$30.6M -$4.23M -$2.28M -117% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$28.3M -$7.14M -$5.88M -466% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$22.4M -$5.19M -$2.45M -89.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$20M -$14M -$19M -380% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$931K -$1.95M +$333K +14.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$1.26M -$1.26M +$1.73M +57.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$2.99M -$2.74M +$1.2M +30.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$4.19M $5.01M +$9.98M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$14.2M -$2.28M +$2.4M +51.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$16.6M -$2.99M +$2.01M +40.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$18.6M -$3.94M +$1.95M +33.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$20.5M -$4.97M -$68.2K -1.39% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-07
Q3 2018 -$20.5M -$4.68M -$465K -11% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$20M -$5M -$718K -16.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$19.3M -$5.89M -$1.93M -48.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$17.4M -$4.9M -$979K -25% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$16.4M -$4.22M -$502K -13.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$15.9M -$4.28M -$371K -9.49% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$15.5M -$3.95M +$911K +18.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$16.4M -$3.92M +$448K +10.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$16.9M -$3.72M +$941K +20.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-09
Q2 2016 -$17.8M -$3.91M +$907K +18.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-09
Q1 2016 -$18.7M -$4.86M -$446K -10.1% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-09
Q4 2015 -$18.3M -$4.37M -$515K -13.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-24
Q3 2015 -$17.7M -$4.66M -$1.52M -48.3% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-24
Q2 2015 -$16.2M -$4.82M -$1.31M -37.4% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-24
Q1 2015 -$14.9M -$4.42M -$1.65M -59.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-24
Q4 2014 -$13.3M -$3.85M -$1.52M -65.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$11.7M -$3.14M -$1.32M -72.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$10.4M -$3.51M -$1.6M -83.4% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$8.84M -$2.77M -$857K -44.9% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$7.98M -$2.33M -$1.29M -123% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 -$6.69M -$1.82M -$24.1K -1.34% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$6.67M -$1.91M -$64.6K -3.49% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$6.6M -$1.91M -$24.8K -1.32% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$6.58M -$1.05M +$1.36M +56.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-21
Q3 2012 -$7.94M -$1.8M +$1.56M +46.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$9.49M -$1.85M +$4.61M +71.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 -$14.1M -$1.88M +$2.03M +51.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$16.1M -$2.4M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-22
Q3 2011 -$3.36M -$988K -41.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$6.46M -$3.27M -103% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 -$3.91M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$2.37M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$3.19M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.